The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
h2 shou ti zuo kang ji zhi liao xiao hua xing kui yang
Author(s): 
Pages: 359-360
Year: Issue:  6
Journal: World Clinical Drugs

Keyword:  消化性溃疡H 2受体拮抗剂罗沙替丁返流性食管炎法莫替丁尼扎替丁临床试验雷尼抑酸药物;
Abstract: <正> 自1976年H2受体拮抗剂西咪替丁应用于临床后,随之出现的雷尼替丁、法莫替丁和尼扎替丁是消化性溃疡治疗的一次革命。它们疗效肯定,市场巨大。此外,至少还有三种新药,即罗沙替丁(roxatidine)、尼芬替丁(nifentidine)和舒福替丁(sufotidine)正在临床试验中。应用H2受体拮抗剂最明确的指征是治疗十二指肠和胃溃疡以及返流性食管炎。
Related Articles
No related articles found